Tag : Hematology

Latest News

New immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trial

Newsemia
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology...
Latest News

COVID-19 Antibody Tests Proliferate, but What Do They Show?

Newsemia
They are being offered to healthcare workers, as well as to the general public, despite uncertainty over what they mean and their reliability. Source link...
Latest News

Medical Meetings May Be Forever Changed

Newsemia
COVID-19 has caused medical conferences to be canceled this spring. Some regular attendees are expressing relief. Will this disruption lead to lasting changes? Source link...
Latest News

Japan Hospital Hematology and Flow Cytometry Markets, 2020 – Agilent Technologies, CellaVision, Roche & Sysmex – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “2020 Japan Hospital Hematology and Flow Cytometry Markets: Supplier Shares, Sales Segment Forecasts and Strategic Profiles of Leading Competitors” report has been added...
Neurology

Arousal Syndrome No Cause for Shame, Doctors Say

Newsemia
PGAD, in which a person feels repeatedly sexually aroused without provocation, has been considered an extremely rare and embarrassing condition, one that has been the...
Gastroenterology

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

Newsemia
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy...
Latest News

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Newsemia
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with...
Latest News

Irutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Newsemia
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912. Source...
Latest News

Aurora Bio, Inc Announces Clinical Data on Lead Program, AUR01, a Novel Systemic Amyloidosis Imaging Tracer, at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition

Newsemia
ORLANDO, Fla.–(BUSINESS WIRE)–Aurora Bio, Inc www.Aurorabioinc.com today announced data for the company’s novel PET radiotracer, AUR01, in development for systemic amyloidosis, was presented by Dr....
Latest News

Rocket Pharmaceuticals Presents Promising Preliminary Results from Phase 1 Trial of Commercial-Grade RP-L102 “Process B” for Fanconi Anemia at 61st American Society of Hematology Annual Meeting

Newsemia
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today...
Latest News

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

Newsemia
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including...
Latest News

Bristol-Myers Squibb Announces Studies Evaluating liso-cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology (ASH) Annual Meeting

Newsemia
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY–Studies Evaluating Liso-Cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy